Elevra Lithium Completes Sale Of Its Rights, Interests And Obligations Associated With E45/2364 To Wildcat For $16M Plus Ongoing Royalty

Shares of lithium-related companies are trading lower amid lithium carbonate price declines in China due to concerns about oversupply and a projected market surplus in 2027. Also, JP Morgan maintained its Neutral rating on Albemarle and lowered its price target from $160 to $140.

Elevra Lithium shares are trading higher after the company announced a binding Spodumene Concentrate Supply Agreement with Mangrove for the long-term supply of spodumene concentrate produced at North American Lithium in Québec.

Elevra Lithium Executes 7-Year Agreement With Mangrove Lithium For Supply Of Spodumene Concentrate Manufacture At North American Lithium in Quebec

North American lithium producer Elevra Lithium Limited ("Elevra") ((ASX:ELV, NASDAQ:ELVR) is pleased to announce that it has executed a binding Spodumene Concentrate Supply Agreement (the "Agreement")

Elevra Lithium Completes Sale of E45/2364 Pegmatite Rights

Elevra Lithium has completed the sale of its E45/2364 exploration rights in Western Australia to Wildcat Resources for A$16 million in total consideration, including A$5 million cash upfront, A$8 million in Wildcat shares, A$3 million deferred cash, and contingent royalty payments. The transaction allows Elevra to reallocate capital to its core North American lithium assets while maintaining upside exposure through royalty participation.